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To the Editor: Hepatitis E virus 
(HEV) is endemic to India (1,2) and 
Central African Republic (3,4), al-
though different strains circulate in 
the countries. In May 2011, a case of 
jaundice and fever in an expatriate In-
dian worker (a 33-year-old man) was 
reported to Institut Pasteur de Bangui, 
Bangui, Central African Republic. 
HEV RNA and IgM were detected in 
serum samples from the patient, and 
liver enzyme levels were raised (ala-
nine aminotransferase 840 U/L, ref-
erence value 11–66 U/L). Symptoms 
lasted for ≈10 days and resolved with-
out specific treatment. The patient was 
working and living at a construction 
site in Central African Republic with 
51 other men (22–62 years of age) 
from India.
 We investigated this case to de-
termine whether it was linked to an 
outbreak and whether disease-control 
measures were needed. The protocol 
for surveillance and investigation was 
approved by the national ethical and 
scientific committee in Central Afri-
can Republic.
Background information and 
blood and stool samples were obtained 
from the patient’s coworkers. The 
Bioelisa HEV IgM 3.0 kit (Biokit, Bar-
celona, Spain), which has sensitivity 
>98%, was used to test serum samples 
for HEV IgM; real-time reverse tran-
scription PCR (rRT-PCR) was used to 
test serum and stool samples for viral 
RNA (5). Test results provided evi-
dence of early HEV infection. Liver 
enzymes (aspartate aminotransferase 
and alanine aminotransferase) were 
measured in serum by using an ABX 
Pentra 400 benchtop analyzer (Horiba 
Medical, Montpellier, France). 
For genetic analysis of HEV 
strains from viremic study participants, 
we performed nested RT-PCR on serum 
and stool samples to amplify a 348-bp 
portion of the open reading frame 2 re-
gion (6). We directly sequenced the pu-
rified amplicons and compared the re-
sulting sequences with HEV sequences 
in GenBank (7) and those from autoch-
thonous HEV cases from 2008–2011. 
ClustalW2 (www.ebi.ac.uk/Tools/msa/
clustalw2/) was used to align sequenc-
es. MEGA5 (8) was used to construct 
a phylogenetic tree (300-nt sequences) 
by the neighbor-joining method. The 
genotypes and subtypes were identified 
as described (7).
The 52 men arrived in Central 
African Republic in several groups 
during July 2010–June 2011. During 
May–July 2011, a total of 40 (77%) 
men had a febrile illness; 9 illnesses 
were accompanied by digestive signs 
or symptoms, such as nausea and 
vomiting (Technical Appendix Table, 
wwwnc.cdc.gov/EID/article/12-0670-
Techapp1.pdf). Only the patient whose 
case was reported was jaundice. Early 
HEV infection was biologically con-
firmed for 11 (21%) men, including 
the -patient whose case was reported; 
8 of the 11 men had IgM only, 1 was 
HEV positive according to rRT-PCR 
and IgM negative, and 2 were HEV 
positive according to rRT-PCR and 
IgM positive. The 2 other men with 
viremia were asymptomatic, but liv-
er enzyme levels were elevated in 1 
of them. 
Illnesses in infected and nonin-
fected men did not differ, and, ex-
cept for the notified case, we cannot 
say with certainty that the illnesses 
were caused by HEV. We found IgG 
against HEV in 14 (34%) uninfected 
men, which is close to the preva-
lence for the general population in 
India (2).
HEV subtype 1a isolates from 
the notified case-patient (serum-de-
rived isolate) and a co-worker (stool-
derived isolate) were sequenced 
(GenBank accession nos. JN863908 
and JQ074213, respectively) and 
found to be 100% similar and to share 
97%– 99% similarity with other HEV 
strains in India and Nepal (Techni-
cal Appendix Figure). The sequences 
obtained from persons with autoch-
thonous HEV (GenBank accession 
nos. JN863909, JN863910, and 
JQ740782) clustered with HEV sub-
type 1e and type 2 strains and were 
closely related to strains from Africa 
and Mexico (93% and 82% similar-
ity, respectively). Similarity between 
strains was not as high for the strain 
from the notified case-patient and 
those from persons with autochtho-
nous infection (87% similarity with 
the subtype 1e strain and 77% simi-
larity with the type 2 strain).
IgM titers typically rise after the 
incubation period, which is >3 weeks 
for HEV (9). Thus, for the purpose of 
this study, we assumed that men who 
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were positive for IgM against HEV 
or who had positive rRT-PCR results 
<3 weeks after their arrival in Cen-
tral African Republic were probably 
infected while in India (Table, study 
participants 2–4 and 9). The notified 
case-patient and study participants 
1, 5, 7, 8, and 10 had positive IgM 
or rRT-PCR results 4–20 weeks after 
arrival (Table) and, thus, could have 
become infected in India or Central 
African Republic. Study participant 
6 was IgM positive >7 months after 
arriving in Central African Republic; 
thus, he was infected locally. Hous-
ing conditions for the workers were 
conducive to waterborne transmis-
sion of HEV, so it is likely that study 
participant 6 was infected with the 
imported strain. However, this partic-
ipant was not viremic, and we cannot 
eliminate the possibility of autoch-
thonous infection.
During the past few decades, 
concern that communicable diseases 
are emerging or re-emerging because 
of population mobility has focused 
mainly on mobility within industrial-
ized countries. However, because of 
humanitarian and economic reasons, 
migration within low-income regions 
is also increasing. Resource-limited 
countries have weak infrastructures; 
thus, the consequences of imported 
outbreaks may be more serious in 
such countries.  Our findings further 
demonstrate the need to improve co-
operation among countries in terms 
of health policy, surveillance, and 
control, particularly in resource-
limited countries. Such countries 
should immediately implement the 
International Health Regulations 
(2005) (10).
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1,	Orissa 2011	Apr	29 NS Mid	Jun + + + 852 791 
2,	Orissa 2011	Jun	4 NS Mid	Jun  +  22 14 
3,	Orissa 2011	Jun	4 Late	Jun Mid	Jun +   26 12 
4,	Orissa 2011	Jun	4 NS Mid	Jun +   25 23 
5,	West	Bengal 2011	Apr	5 Late	Jun Mid Jun +   31 23 
6,	West	Bengal 2010	Oct	10 Early	Jul Mid	Jun +   9 7 
7,	Orissa 2011	Apr	29 Late	May Mid	Jun +   23 18 
8,	Karnatanka 2011	Feb	23 Early	May Mid	Jun +   16 7 
9,	Orissa 2011	Jun	4 Early	Jul Mid	Jun +   19 12 
10,	West	Bengal 2011	Apr	5 Early	Jul Mid	Jun +   24 23 
NC,	Orissa 2011	Apr	29 Early	Jun Early	Jun + + NA 2,100 840 
*rRT-PCR,	real-time	reverse	transcription	PCR ;	AST, aspartate	aminotransferase;	ALT, alanine	aminotransferase; NS,	not	symptomatic; NC,	participant	
whose case	was	notified ;	NA,	not available. 
†Reference value 5–34 U/L. 
‡Reference value 11–66	U/L. 
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To the Editor: Rickettsia si-
birica mongolitimonae, a member of 
the tick-borne spotted fever group 
(SFG) of rickettsia, was first isolated 
from Hyalomma asiaticum ticks in 
China (1). The first human case was 
described in France in 1996, and 7 
new cases were described in 2005 
(1). This rickettsiosis was named 
lymphangitis-associated rickettsiosis 
because lymphangitis was observed 
in 50% of the patients (1). Only 17 
cases have been reported, for which 
7 patients had lymphangitis, and 13 
had inoculation eschars, including 2 
patients with 2 eschars (1,2). We re-
port a cluster of cases of R. sibirica 
mongolitimonae infection.
Patient 1, a 73-year-old man in 
France, had fever, rash, lymphade-
nopathies, and an axillary inoculation 
eschar in February 2011. A diagnosis 
of lymphangitis-associated rickett-
siosis was suspected because of the 
season (most cases occur in spring in 
France) and clinical manifestations. 
The patient was confined to bed for 
several weeks after surgical place-
ment of a knee prosthesis when his 
disease occurred; the domestic cat 
was suspected to have introduced 
ticks into the home.
In April, his wife (67 years of 
age) (patient 2) became febrile, had 
popliteal lymphadenopathies associ-
ated with lymphangitis, and had an 
eschar on the leg from which a swab 
specimen was obtained. Patient 3 was 
their neighbor; he had the same symp-
toms in March 2011 but samples were 
not collected from him.
None of patients reported tick 
bites, but they were in regular con-
tact with animals, including a cat, a 
dog, horses, and birds. Both patients 
who lived with the cat reported that it 
would return home with ticks. Infec-
tions in these patients were success-
fully treated with doxycycline.
An immunofluorescence assay 
for antibodies against SFG antigens 
showed IgG/IgM titers of 128/0 for 
patient 1 and 64/16 for patient 2 (3). 
DNA was extracted from the skin 
swab specimen of patient 2 by us-
ing the QIAamp Mini Kit (QIAGEN, 
Hilden, Germany). A fragment of the 
citrate synthase gene of Rickettsia spp. 
was amplified by PCR and sequenced. 
The sequence show 99.7% homology 
with that of the same gene sequence 
of R. sibirica mongolitimonae in Gen-
Bank (accession no. DQ423370) (4).
Ticks were collected from the 
property of the 2 patients: from the 
garden by flagging vegetation (3), 
from animals, and near the cat litter 
(Table). SFG rickettsiae were detected 
by specific quantitative PCR. Species 
identification was confirmed by spe-
cific quantitative PCR for R. massiliae 
and sequencing of outer membrane 
protein A gene for others species (5). 
A negative control (sterile water) and 
positive control (DNA from R. monta-
nensis or R. massiliae) were included 
in each PCR.
Ticks were morphologically iden-
tified as adult Rhipicephalus sanguin-
eus. Molecular identification of these 
ticks harboring rickettsiae was per-
formed by amplification of the 12S 
rRNA gene. DNA from R. massiliae 
was found in 3 ticks collected from 
the dog and near the cat litter morpho-
logically identified as Rh. sanguineus. 
This DNA showed 98% homology 
with the sequence in GenBank (acces-
sion no. AY559843). R. sibirica mon-
golitimonae with 99.8% homology 
for the outer membrane protein gene 
sequence in GenBank (accession no. 
DQ097082)  was isolated from 1 tick 
collected from the cat. This tick was 
identified as Rh. pusillus and showed 
99.7% homology with the sequence in 
GenBank (accession no. FJ536547). 
R. massiliae was cultured from an Rh. 
sanguineus tick, and R. sibirica mon-
golitimonae was cultured from an Rh. 
pusillus tick.
A cluster of 1 documented case 
and 2 probable cases of lymphangitis-
associated rickettsiosis in southern 
France was linked to a cat and Rh. 
pusillus ticks. Infection with R. mas-
siliae for the 2 probable case-patients 
was unlikely because clinical findings 
	 Emerging	Infectious	Diseases	•	www.cdc.gov/eid	•	Vol.	19,	No.	2,	February	2013	 337













Garden 2 ND 0 0 
Dog 21 Rhipicephalus 
sanguineus 
2	(R. massiliae) 0 
Cat	litter 7 ND 1	(R. massiliae) 1	(R. massiliae) 




Scrub	land 5 ND 0 0 
*ND,	not	done. 
†Based	on	12S	rRNA	gene.	All	adult	ticks	were	morphologically	identified	as	Rh. sanguineus. 
 
